We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+5.89%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$35.5B
AUM Growth
+$586M
Cap. Flow
-$946M
Cap. Flow %
-2.67%
Top 10 Hldgs %
25.54%
Holding
2,317
New
189
Increased
687
Reduced
1,108
Closed
152

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$418M
2
ED icon
Consolidated Edison
ED
+$212M
3
CCI icon
Crown Castle
CCI
+$103M
4
TGT icon
Target
TGT
+$93.8M
5
SAGE
Sage Therapeutics
SAGE
+$72M

Sector Composition

Rank Sector Weight
1 Consumer Staples 14.38%
2 Healthcare 14.1%
3 Communication Services 10.76%
4 Technology 10.06%
5 Utilities 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIT icon
1676
Applied Industrial Technologies
AIT
$11.7B
$45K ﹤0.01%
659
+154
+30% +$9.8K
CCNE icon
1677
CNB Financial Corp
CCNE
$1.02B
$45K ﹤0.01%
1,709
+668
+64% +$18.7K
PFGC icon
1678
Performance Food Group
PFGC
$14.2B
$45K ﹤0.01%
1,345
-35
-3% -$1.03K
GWB
1679
DELISTED
Great Western Bancorp, Inc.
GWB
$45K ﹤0.01%
1,120
-4,386
-80% -$177K
GHDX
1680
DELISTED
Genomic Health, Inc.
GHDX
$45K ﹤0.01%
1,314
-35
-3% -$1.12K
BLMN icon
1681
Bloomin' Brands
BLMN
$688M
$44K ﹤0.01%
2,081
-383
-16% -$7.34K
ICPT
1682
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$43K ﹤0.01%
732
-17
-2% -$1.07K
PLAB icon
1683
Photronics
PLAB
$1.64B
$42K ﹤0.01%
4,929
-6,701
-58% -$61.2K
TIVO
1684
DELISTED
Tivo Inc
TIVO
$42K ﹤0.01%
2,689
-72
-3% -$1.25K
ORIT
1685
DELISTED
Oritani Financial Corp. New
ORIT
$42K ﹤0.01%
2,551
-69
-3% -$1.16K
AMNB
1686
DELISTED
American National Bankshares Inc
AMNB
$42K ﹤0.01%
1,106
RMAX
1687
DELISTED
RE/MAX Holdings
RMAX
$40K ﹤0.01%
819
-22
-3% -$1.26K
SNCR
1688
DELISTED
Synchronoss Technologies
SNCR
$40K ﹤0.01%
491
CYS
1689
DELISTED
CYS Investments Inc.
CYS
$40K ﹤0.01%
5,027
-132
-3% -$1.09K
ZUMZ icon
1690
Zumiez
ZUMZ
$206M
$39K ﹤0.01%
1,896
+740
+64% +$14.2K
MLNT
1691
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$39K ﹤0.01%
+488
New +$36.1K
CACI icon
1692
CACI
CACI
$13.9B
$38K ﹤0.01%
290
-58
-17% -$7.83K
PEB icon
1693
Pebblebrook Hotel Trust
PEB
$2.05B
$38K ﹤0.01%
1,020
-10,027
-91% -$371K
MTGE
1694
DELISTED
MTGE Investment Corp. Common Stock
MTGE
$38K ﹤0.01%
2,059
-55
-3% -$1.03K
TSBK icon
1695
Timberland Bancorp
TSBK
$365M
$37K ﹤0.01%
1,378
WWW icon
1696
Wolverine World Wide
WWW
$1.62B
$37K ﹤0.01%
1,171
-26
-2% -$750
KFY icon
1697
Korn Ferry
KFY
$4.26B
$36K ﹤0.01%
875
-24
-3% -$996
RYZ
1698
Ryerson Holding Corp
RYZ
$1.29B
$36K ﹤0.01%
3,466
-987
-22% -$9.21K
GTS
1699
DELISTED
Triple-S Management Corporation
GTS
$36K ﹤0.01%
1,506
+1,049
+230% +$25.6K
AMN icon
1700
AMN Healthcare
AMN
$1.36B
$35K ﹤0.01%
713
-108
-13% -$4.92K

Similar funds

Federated Hermes's Q4 2017 Portfolio in Review

As of Q4 2017, Federated Hermes held 2,317 positions worth $35.5B, up 1.7% from $34.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Federated Hermes's Q4 2017 filing shows 189 new, 687 increased, 1,108 reduced and 152 closed positions. Its largest new stake was Azul: 1,190,200 shares worth $28.4M. The largest sale was AbbVie, an estimated $418M.

By sector, the portfolio is most concentrated in Consumer Staples at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Communication Services.

  • Federated Hermes's largest Q4 2017 buy was Azul: 1,190,200 shares worth $28.4M.
  • Federated Hermes added most to British American Tobacco in Q4 2017, an estimated $104M increase.
  • Federated Hermes's biggest Q4 2017 reduction was AbbVie, cutting an estimated $418M.
  • Federated Hermes fully exited iShares Biotechnology ETF in Q4 2017, selling an estimated $36.1M.
  • Federated Hermes's ten largest holdings make up 26% of its $35.5B portfolio in Q4 2017.
  • Federated Hermes opened 189 new positions and closed 152 in Q4 2017.
  • Federated Hermes's portfolio value rose 1.7% quarter-over-quarter to $35.5B.

Based on Federated Hermes's 13F filing for Q4 2017, filed 14 Feb 2018.